Cite
HARVARD Citation
Chen, L. et al. (2018). Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology. pp. 548-557. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, L. et al. (2018). Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology. pp. 548-557. [Online].